KoBioLabs

KoBioLabs, Inc. is a biotechnology company based in Seoul, South Korea, that specializes in microbiome therapeutics. The company is dedicated to researching and developing treatments for various conditions, particularly metabolic, immune, and neurological diseases. By leveraging the potential of the microbiome, KoBioLabs aims to create innovative therapeutic solutions to address these health challenges.

GwangPyo Ko

Founder / CEO

1 past transactions

Webiom

Venture Round in 2022
Webiome, a company specializing in microbiome lactobacilli.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.